Clinical Trial Update: Perioperative Adebrelimab and Chemotherapy in Esophageal and Esophagogastric Junction Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating perioperative Adebrelimab plus chemotherapy for esophageal and esophagogastric junction carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophagogastric Junction Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Xijing Hospital | Conditions: Adebrelimab, Esophageal Cancer | Phase 2 | Status: UNKNOWN